| Sign In to gain access to subscriptions and/or personal tools. |
Molecular Profiling of CancerScience Applications International Corporation, National Cancer Institute, Bethesda, Maryland, USA, jgill{at}mail.nih.gov
Pathogenetics Unit, National Cancer Institute, Bethesda, Maryland, USA
Pathogenetics Unit, National Cancer Institute, Bethesda, Maryland, USA
Battelle, Pacific Northwest National Laboratory, Richland, Washington, USA
Pathogenetics Unit, National Cancer Institute, Bethesda, Maryland, USA
Federal Institute of Intellectual Property, Bern, Switzerland
Center for Biologics and Research, Food and Drug Administration, Bethesda, Maryland, USA
Pathogenetics Unit, National Cancer Institute, Bethesda, Maryland, USA
Pathogenetics Unit, National Cancer Institute, Bethesda, Maryland, USA The objective of molecular profiling of cancer is to determine the differential expression of genes and proteins from human tissue in the progression from normal precursor tissue to preneoplastic tissue to cancer in order to discover diagnostic, prognostic, and therapeutic markers. With the development of high-throughput analytical techniques such as microarrays and 2-D PAGE as well as the development of tools for cell procurement from histological sections such as laser capture microdissection (LCM), it is now possible to perform molecular analyses on specific cell populations from tissue. Since recognition of specific cell populations is critical, there is a need to optimize fixation and embedding not only to improve preservation of biomolecules, but also to maintain excellent histology. We have shown that 70% ethanol fixation of prostate tissue improves the recovery of DNA, RNA, and proteins over routine formalin fixation and maintains histological quality comparable to formalin. There is also a need to develop new technologies in order to expand the range of tissue types that can be analyzed. The development and applications of Layered Expression Scanning (LES) for the molecular analysis of whole tissue sections are discussed.
Key Words: Molecular profiling expression cancer microdissection expression protein gene.
Toxicologic Pathology, Vol. 32, No. 1 suppl,
67-71 (2004) This article has been cited by other articles:
|
|||||||||||||||

